Unrestricted availability of intracoronary stents is associated with decreased abrupt vascular closure rates and improved early clinical outcomes
W. Warren Suh MD, MPH
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota
Search for more papers by this authorDiane E. Grill MS
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota
Search for more papers by this authorCharanjit S. Rihal MD
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota
Search for more papers by this authorMalcolm R. Bell MB, BS
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota
Search for more papers by this authorDavid R. Holmes Jr. MD
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota
Search for more papers by this authorCorresponding Author
Kirk N. Garratt MD
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota
Mayo Clinic and Foundation, 200 First St. SW, Rochester, MN 55905Search for more papers by this authorW. Warren Suh MD, MPH
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota
Search for more papers by this authorDiane E. Grill MS
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota
Search for more papers by this authorCharanjit S. Rihal MD
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota
Search for more papers by this authorMalcolm R. Bell MB, BS
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota
Search for more papers by this authorDavid R. Holmes Jr. MD
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota
Search for more papers by this authorCorresponding Author
Kirk N. Garratt MD
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota
Mayo Clinic and Foundation, 200 First St. SW, Rochester, MN 55905Search for more papers by this authorAbstract
The purpose of this study was to determine whether the unrestricted availability of intracoronary stents is affecting abrupt vascular closure rates and early clinical outcomes. Intracoronary stents have improved procedural outcome despite their application in more complex lesions, but the impact of unrestricted availability of stents on abrupt closure and early clinical outcomes is unknown. Two cohorts were identified retrospectively from a coronary intervention registry: patients treated between 1988 and 1992 (n = 3,617) when stents were not generally available, and patients treated between 1994 and 1997 (n = 4,518) when stents were freely available. The late cohort patients consisted of more females; it also had greater comorbidity and more complex presentation. However, there was a significant reduction in the abrupt closure rates between the two time periods (7% vs. 4%, P < 0.0001). After adjusting for female gender, thrombus, and lesion angulation, the late cohort remained significantly associated with decreased odds of abrupt closure (odds ratio [OR] = 0.62, 95% upper and lower confidence intervals [CI] = 0.52–0.75, P = 0.0001). The late cohort also had decreased in-hospital mortality (OR = 0.91, CI = 0.86–0.95, P = 0.0002) and major adverse clinical event (OR = 0.93, CI = 0.91–0.96, P = 0.0001). Unrestricted availability of intracoronary stents is associated with reduced abrupt closure rates and improved early clinical outcomes among patients undergoing coronary intervention despite treatment of high-risk patients. Cathet Cardiovasc Intervent 2002;55:294–302. © 2002 Wiley-Liss, Inc.
REFERENCES
- 1 Bredlau CE, Roubin GS, Leimgruber PP, Douglas JS Jr, King SB III, Gruentzig AR. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 1985; 72: 1044–1052.
- 2 Simpfendorfer C, Belardi J, Bellamy G, Galan K, Franco I, Hollman J. Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty. Am J Cardiol 1987; 59: 267–269.
- 3 Ellis SG, Roubin GS, King SB III, et al. In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8,207 procedure. J Am Coll Cardiol 1988; 11: 211–216.
- 4 Sinclair IN, McCabe CH, Sipperly ME, Baim DS. Predictors, therapeutic options and long-term outcome of abrupt reclosure. Am J Cardiol 1988; 61: 61G–66G.
- 5 Holmes DR Jr, Holubkov R, Vlietstra RE, et al. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol 1988; 12: 1149–1155.
- 6 Detre KM, Holmes DR Jr, Holubkov R, et al. Incidence and consequences of periprocedural occlusion. The 1985–1986 National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1990; 82: 739–750.
- 7 de Feyter PJ, van den Brand M, Laarman GJ, van Domburg R, Serruys PW, Suryapranata H. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up. Circulation 1991; 83: 927–936.
- 8 Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic, and therapeutic profile. J Am Coll Cardiol 1992; 19: 926–935.
- 9 Baim DS, Kent KM, King SB III, et al. Evaluating new devices: acute (in-hospital) results from the New Approaches of Coronary Intervention Registry. Circulation 1994; 89: 471–481.
- 10 Holmes DR Jr, Simpson JB, Berdan LG, et al. Abrupt closure: the CAVEAT I experience. Coronary Angioplasty Versus Excisional Atherectomy Trial. J Am Coll Cardiol 1995; 26: 1494–1500.
- 11 Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489–495.
- 12 Fishman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496–501.
- 13Anonymous. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of platelet IIb/IIIa inhibitor for stenting. Lancet 1998; 352: 87–92.
- 14 Brown DL, George CJ, Steenkiste AR, et al. High-speed rotational atherectomy of human coronary stenoses: acute and one-year outcomes from the New Approaches to Coronary Intervention (NACI) registry. Am J Cardiol 1997; 80: 60K–67K.
- 15 Preisack MB, Athanasiadis A, Voelker W, Baumbach A, Karsch KR. Acute closure during coronary excimer laser angioplasty and conventional balloon dilation: a comparison of management outcome and prediction. Eur Heart J 1993; 14: 195–204.
- 16Anonymous. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985; 312: 932–936.
- 17 Vlietstra RE, Holmes DR Jr, Smith HC, Hartzler GO, Orszulak TA. Percutaneous transluminal coronary angioplasty: initial Mayo Clinic experience. Mayo Clin Proc 1981; 56: 287–293.
- 18 Kaufmann UP, Garratt KN, Vlietstra RE, Menke KK, Holmes DR Jr. Coronary atherectomy: first 50 patients at the Mayo Clinic. Mayo Clin Proc 1989; 64: 747–752.
- 19 Bertrand ME, Bauters C, Lablanche JM. Percutaneous coronary rotational angioplasty with the Rotablator. In: EJ Topol, editor. Textbook of interventional cardiology. Vol 1. Philadelphia: WB Saunders; 1994. p 659–667.
- 20 Sketch ME, Labinaz M, Stack RS. Extraction atherectomy. In: EJ Topol, editor. Textbook of interventional cardiology. Vol 1. Philadelphia: WB Saunders; 1994. p 668–677.
- 21 Litvack F. Excimer laser coronary angioplasty. In: EJ Topol, editor. Textbook of interventional cardiology. Vol 2. Philadelphia: WB Saunders; 1994. p 840–858.
- 22 Ellis SE, Cannon AD, Roubin GS, Whitlow PL, de Jaegere PP, Serruys PW. Coronary stenting. In: EJ Topol, editor. Textbook of interventional cardiology. Vol 2. Philadelphia: WB Saunders; 1994. p 702–741.
- 23 Campeau L. Grading of angina pectoris. Circulation 1976; 54: 522–523.
- 24 Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multi-vessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990; 82: 1193–1202.
- 25 Mabin TA, Holmes DR, Smith HC, et al. Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985; 5: 198–202.
- 26 Ellis SG, Roubin GS, King SB III, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988; 77: 372–379.
- 27 Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med 1993; 329: 221–227.
- 28 Warth DC, Leon MB, O'Neill W, Zacca N, Polissar NL, Buchbinder M. Rotational atherectomy multicenter registry: acute results, complications and 6-month angiographic follow-up in 709 patients. J Am Coll Cardiol 1994; 24: 641–648.
- 29 Baumbach A, Bittl JA, Fleck E, et al. Acute complications of excimer laser coronary angioplasty: a detailed analysis of multicenter results. Coinvestigators for the US and European Percutaneous Excimer Laser Coronary Angioplasty (PELCA) Registries. J Am Coll Cardiol 1994; 23: 1305–1313.
- 30
Suh WW,
Grill DE,
Holmes DR Jr,
Bell MR,
Berger PB,
Garratt KN.
Clinical, angiographic and procedural correlates of abrupt vascular closure during coronary intervention. A 10-year experience at Mayo Clinic.
Cathet Cardiovasc Intervent
1999;
47:
391–395.
10.1002/(SICI)1522-726X(199908)47:4<391::AID-CCD1>3.0.CO;2-9 CAS PubMed Web of Science® Google Scholar
- 31 Hasdai D, Berger PB, Bell MR, Rihal CS, Garratt KN, Holmes DR Jr. The changing face of coronary interventional practice: the Mayo Clinic experience. Arch Intern Med 1997; 157: 677–682.
- 32 Suryapranata H, van't Hof AW, Hoorntje JC, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97: 2502–2505.
- 33 Ellis SG, Lincoff AM, Miller D, et al. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG investigators. Evaluation of 7E3 for the prevention of ischemic complications. Evaluation of PTCA to improve long-term outcome with abciximab GPIIb/IIIa receptor blockade. J Am Coll Cardiol 1998; 32: 1619–1623.
- 34 Lincoff AM. Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization. Am J Cardiol 1998; 82: 36P–42P.
- 35 Thel MC, Califf RM, Tcheng JE, et al. Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. Am Heart J 1999; 137: 264–273.
- 36 Jacobsen SJ, Xia Z, Campion ME, Darby CH, Plevak MF, Seltman KD, Melton LJ III. Potential effect of authorization bias on medical record research. Mayo Clin Proc 999; 74: 330–338.